Merck | Laba Kotor Pada Penjualan



Gross Profit On Sales Perubahan Tanggal
AbbVie USD 10.71B 458M 2024-12
Abbott USD 5.92B 114M 2025-03
ALKERMES USD 257.31M 110.81M 2025-03
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Indivior 222M 54M 2025-03
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.81B 296M 2025-04
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Novartis USD 10.24B 313M 2024-12
Novo Nordisk 65.2B 5.19B 2025-03
Pacira USD 134.62M 12.75M 2025-03
Perrigo USD 392.3M 6.4M 2025-03
Pfizer USD 11.12B 987M 2025-03
Prestige Brands USD 170.01M 8.96M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Sanofi EUR 5.36B 4.71B 2024-12
United Therapeutics USD 701.9M 41.9M 2025-03
Zoetis USD 1.6B 12M 2025-03



Merck Laba Kotor Pada Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Jul 2025.